BioCryst Pharmaceuticals Stock Price. Everything You Need To Know About The BioCryst Pharmaceuticals Stock!
BioCryst Pharmaceuticals, Inc. is a commercial-stage biotechnology company that discovers novel, oral, and small-molecule medicines. The company is headquartered in Durham, North Carolina and currently employs 531 full-time employees. The firm focuses on oral treatments for rare diseases, in which unmet medical needs exist and an enzyme plays the key role in the biological pathway of the disease. Its marketed products include oral, once-daily ORLADEYO for the prevention of hereditary angioedema (HAE) attacks and RAPIVAB (peramivir injection) for the treatment of acute uncomplicated influenza in the United States. Its other products and product candidates include BCX10013, RAPIACTA (peramivir injection), BCX9930, BCX9250, PERAMIFLU (peramivir injection), galidesivir, and early-stage discovery programs. BCX10013, is a potent and specific Factor D inhibitor. RAPIACTA focuses on uncomplicated seasonal influenza. BCX9930 is an oral, potent, and selective small molecule inhibitor of Factor D. Galidesivir is a broad-spectrum antiviral that is active against viral families.
BioCryst Pharmaceuticals Stock Price. Everything You Need To Know About The BioCryst Pharmaceuticals Stock! performance
- Employees 531
- Company HQ Durham
- Website https://www.biocryst.com/
- BCRX Asset Type Common Stock
- BCRX Market Capitalization 895.5M
- Earnings Per Share -1.18
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth 0
Are you interested in investing in the pharmaceutical industry? Look no further than BioCryst Pharmaceuticals, a cutting-edge company that is revolutionizing the healthcare sector. If you’re from Malaysia, Thailand, Indonesia, or Vietnam, you can now invest in this promising stock through Zorion. BioCryst Pharmaceuticals specializes in the development and commercialization of novel therapeutics for rare and infectious diseases. With Zorion’s investment insights and recommendations, you can make informed decisions about investing in BioCryst Pharmaceuticals. Additionally, Zorion provides valuable resources and educational materials to help you expand your investment knowledge and potentially maximize your returns. Don’t miss this opportunity to invest in one of the most innovative pharmaceutical companies in the market.
